Andrea Bileck

29PUBLICATIONS
180CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsMolecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Mar 23, 2026
Mesoporous Silica Nanoparticles-Based Formulations for Enhanced Oral Delivery of Peptide Drugs: A Case Study on Insulin.

Claudia Iriarte-Mesa, Estelle Juère, Andrea Bileck

|Mar 20, 2026
Analysis of postmortem dermal extracts is an efficient illicit drug screening method supporting forensic medicine.

Daniel Wasinger, Katharina Stolz, Michael Wolf

|Jan 27, 2026
Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) Derivatives.

Julia H Bormio Nunes, Christina Hacker, Monika Caban

|Jan 05, 2026
A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System.

Sophie R Thomas, Thomas Iellici, Mihyun Park

|Aug 06, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.

Alexander Rosner, Lukas Skos, Theresa Mendrina

|Jun 27, 2025
Proteomic Analysis of FFPE Tissue Samples Identifies Potential Molecular Mechanisms Mediating Resistance to Radiotherapy in Rectal Cancer.

Tobias Zott, Michael Wolf, Günter Plessl-Walder

Pageof 5

Frequent Collaborators

23 joint publications

Christopher Gerner

12 joint publications

Samuel Meier-Menches

6 joint publications

Lukas Janker

5 joint publications

Benjamin Neuditschko